
|Articles|October 5, 2018
AJMC® in the Press, October 5, 2018
Author(s)AJMC Staff
Coverage of our peer-reviewed research and news reporting in the healthcare and mainstream press.
Advertisement
An article from
Advertisement
Advertisement
Advertisement
Trending on AJMC
1
Newer Agents, New Advantages: Brexpiprazole, Cariprazine, and Lumateperone in MDD
2
Dosing, Tolerability, and Formulary Impact: Aripiprazole and Quetiapine XR in MDD
3
5 August FDA Approvals Marked by Novelty, Pushback
4
Cross-Trial Vitiligo Data: What Payers Can and Can't Compare
5




